CAFC Applies Minimum Contacts Analysis of Acorda to Infringement Case Over Eylea BiosimilarThe Federal Circuit confirmed that biosimilar approval applications can establish sufficient jurisdictional links for legal proceedings.
Biologics Patent Enforcement: Regeneron Patents Block Biosimilar Entry for EYLEAFederal Circuit upholds injunctions against biosimilars of EYLEA, preserving Regeneron's $6 billion market exclusivity.